| TMP-SMX | trimethoprim-sulfamethaxole; trimethoprim-sulfamethoxazole |
|---|---|
| TMP/SMX | Trimethoprim-Sulfamethoxazole(= Bactrim) |
| SULF-PRIM | sulfamethoxazole and trimethoprim |
| SXT | sulfamethoxazole-trimethoprim [mixture] |
| TRM-SMX | trimethoprim-sulfamethoxazole |
| ST | Sulfamethoxazole-Trimethoprim |
|---|---|
| SMX-TMP | Sulfamethoxazole-trimethoprim |
| TMP-SMX | Trimethoprim Sulfamethoxazole |
| TMP-SMZ | Trimethoprim-Sulfamethoxazole |
| TS | Trimethoprim-Sulfamethoxazole |
| trimethoprim-sulfamethoxazole | A drug combination consisting of a dihydrofolate reductase inhibitor (trimethoprim) and a sulfonamide antibacterial drug (sulfamethoxazole). The drug combination is synergistic as the drugs interfere with two successive steps in the formation/utilization of folic acid by microorganisms. Used to treat many infectious diseases. (05 Mar 2000) |
|---|---|
| trimethoprim-sulfamethoxazole combination | <chemical> 4-amino-n-(5-methyl-3-isoxazolyl)benzenesulfonamide mixture with 5-((3,4,5-trimethoxyphenyl)methyl)- 2,4-pyrimidinediamine. This drug combination has proved to be an effective therapeutic agent with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including pneumocystis carinii pneumonia in aids, but is the drug of choice for urinary infection. Pharmacological action: anti-infective agents, anti-infective agents, urinary, antimalarials. Chemical name: Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, mixt. With 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine (12 Dec 1998) |
| sulfamethoxazole | <chemical> A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. Pharmacological action: anti-infective agents, Chemical name: Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)- (12 Dec 1998) |
| trimethoprim | <drug> A drug that inhibits the reduction of dihydrofolate to tetrahydrofolate (a later step than that inhibited by sulphonamides). Selective for some bacterial dihydrofolate reductases and often used in conjunction with sulphonamides. (19 Jan 1998) |
| trimethoprim resistance | Nonsusceptibility of a bacterium to the action of trimethoprim. (12 Dec 1998) |
| amorphous insulin zinc suspension | Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection. Synonym: amorphous insulin zinc suspension, semilente insulin. (05 Mar 2000) |
| magnesia and alumina oral suspension | A mixture of magnesium hydroxide and variable amounts of aluminum oxide; used as an antacid. (05 Mar 2000) |
| chromic phosphate P 32 colloidal suspension | A pure beta-emitting colloidal, nonabsorbable radiopharmaceutical administered into body cavities such as the pleural or peritoneal spaces to control malignant effusions. See: sodium phosphate P 32. (05 Mar 2000) |
| Coffey suspension | <procedure, surgery> An operative technique following partial excision of the cornu, as in salpingectomy, whereby the broad and the round ligament are sutured over the cornual wound to restore continuity of the peritoneum and to suspend the uterus on the operated side. (05 Mar 2000) |
| craniofacial suspension wiring | A method of wiring using areas of bones not contiguous with the oral cavity for the support of fractured jaw segments (e.g., pyriform aperture, zygomatic arch, zygomatic process of the frontal bone). (05 Mar 2000) |
| crystalline insulin zinc suspension | A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours. Synonym: crystalline insulin zinc suspension. (05 Mar 2000) |
| prompt insulin zinc suspension | Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection. Synonym: amorphous insulin zinc suspension, semilente insulin. (05 Mar 2000) |
| Sayre's suspension apparatus | Archaic term for Sayre's suspension traction. (05 Mar 2000) |
| Sayre's suspension traction | Spinal traction obtained by vertical suspension of the patient by means of a head halter. (05 Mar 2000) |
| hindlimb suspension | Technique for limiting use, activity, or movement by immobilizing or restraining animal by suspending from hindlimbs or tails. This immobilization is used to simulate some effects of reduced gravity and study weightlessness physiology. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|